1 Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Overview 1.1 Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Overview 1.2 Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Segment by Type 1.2.1 10 Tables 1.2.2 30 Tables 1.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size by Type 1.3.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size Overview by Type (2016-2027) 1.3.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.2 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Type (2016-2021) 2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Competition by Company 2.1 Global Top Players by Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (2016-2021) 2.2 Global Top Players by Efavirenz/Tenofovir/Emtricitabine Combination Drug Revenue (2016-2021) 2.3 Global Top Players Efavirenz/Tenofovir/Emtricitabine Combination Drug Price (2016-2021) 2.4 Global Top Manufacturers Efavirenz/Tenofovir/Emtricitabine Combination Drug Manufacturing Base Distribution, Sales Area, Product Type 2.5 Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Competitive Situation and Trends 2.5.1 Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Efavirenz/Tenofovir/Emtricitabine Combination Drug as of 2020) 2.7 Date of Key Manufacturers Enter into Efavirenz/Tenofovir/Emtricitabine Combination Drug Market 2.8 Key Manufacturers Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Efavirenz/Tenofovir/Emtricitabine Combination Drug Status and Outlook by Region 3.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size by Region 3.2.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Region (2016-2021) 3.2.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Region (2016-2021) 3.2.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Region 3.3.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Region (2022-2027) 3.3.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Region (2022-2027) 3.3.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug by Application 4.1 Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Drug Center 4.1.4 Other 4.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size by Application 4.2.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size Overview by Application (2016-2027) 4.2.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.2 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Breakdown by Application (2016-2021) 5 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug by Country 5.1 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size by Country 5.1.1 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2016-2021) 5.1.2 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2016-2021) 5.2 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Country 5.2.1 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2022-2027) 5.2.2 North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2022-2027) 6 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug by Country 6.1 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size by Country 6.1.1 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2016-2021) 6.1.2 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2016-2021) 6.2 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Country 6.2.1 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2022-2027) 6.2.2 Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2022-2027) 7 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug by Region 7.1 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size by Region 7.1.1 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Region 7.2.1 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Region (2022-2027) 8 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug by Country 8.1 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size by Country 8.1.1 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2016-2021) 8.1.2 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2016-2021) 8.2 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Country 8.2.1 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2022-2027) 8.2.2 Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2022-2027) 9 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug by Country 9.1 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Historic Market Size by Country 9.1.1 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Forecasted Market Size by Country 9.2.1 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Efavirenz/Tenofovir/Emtricitabine Combination Drug Business 10.1 Gilead Sciences 10.1.1 Gilead Sciences Corporation Information 10.1.2 Gilead Sciences Introduction and Business Overview 10.1.3 Gilead Sciences Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Gilead Sciences Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.1.5 Gilead Sciences Recent Development 10.2 Cipla 10.2.1 Cipla Corporation Information 10.2.2 Cipla Introduction and Business Overview 10.2.3 Cipla Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Gilead Sciences Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.2.5 Cipla Recent Development 10.3 Emcure Pharmaceuticals 10.3.1 Emcure Pharmaceuticals Corporation Information 10.3.2 Emcure Pharmaceuticals Introduction and Business Overview 10.3.3 Emcure Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Emcure Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.3.5 Emcure Pharmaceuticals Recent Development 10.4 Mylan Pharmaceuticals 10.4.1 Mylan Pharmaceuticals Corporation Information 10.4.2 Mylan Pharmaceuticals Introduction and Business Overview 10.4.3 Mylan Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Mylan Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.4.5 Mylan Pharmaceuticals Recent Development 10.5 Sun Pharmaceutical Industries 10.5.1 Sun Pharmaceutical Industries Corporation Information 10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview 10.5.3 Sun Pharmaceutical Industries Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Sun Pharmaceutical Industries Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.5.5 Sun Pharmaceutical Industries Recent Development 10.6 Veritaz Healthcare 10.6.1 Veritaz Healthcare Corporation Information 10.6.2 Veritaz Healthcare Introduction and Business Overview 10.6.3 Veritaz Healthcare Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Veritaz Healthcare Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.6.5 Veritaz Healthcare Recent Development 10.7 Alkem Laboratories 10.7.1 Alkem Laboratories Corporation Information 10.7.2 Alkem Laboratories Introduction and Business Overview 10.7.3 Alkem Laboratories Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Alkem Laboratories Efavirenz/Tenofovir/Emtricitabine Combination Drug Products Offered 10.7.5 Alkem Laboratories Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Efavirenz/Tenofovir/Emtricitabine Combination Drug Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Efavirenz/Tenofovir/Emtricitabine Combination Drug Industrial Chain Analysis 11.4 Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Efavirenz/Tenofovir/Emtricitabine Combination Drug Distributors 12.3 Efavirenz/Tenofovir/Emtricitabine Combination Drug Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 10 Tables Table 2. Major Company of 30 Tables Table 3. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (K Pcs) Table 5. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type (2016-2021) Table 6. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (US& Million) Table 7. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Share in Value by Type (2016-2021) Table 8. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2022-2027) & (K Pcs) Table 10. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type (2022-2027) Table 11. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2022-2027) & (US$ Million) Table 12. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type (2022-2027) Table 13. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (K Pcs) Table 15. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 17. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2021) & (US$ Million) Table 24. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Company (2016-2021) & (K Pcs) Table 25. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Share by Company (2016-2021) Table 26. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Revenue Share by Company (2016-2021) Table 28. Global Market Efavirenz/Tenofovir/Emtricitabine Combination Drug Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Efavirenz/Tenofovir/Emtricitabine Combination Drug as of 2020 Table 32. Date of Key Manufacturers Enter into Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Table 33. Key Manufacturers Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2016-2021) & (K Pcs) Table 37. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Region (2016-2021) Table 38. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2016-2021) & (US$ Million) Table 39. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Region (2016-2021) Table 40. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2022-2027) & (K Pcs) Table 42. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Region (2022-2027) Table 43. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2022-2027) & (US$ Million) Table 44. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Region (2022-2027) Table 45. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (K Pcs) Table 48. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Application (2016-2021) Table 49. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 50. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application (2016-2021) Table 51. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2022-2027) & (K Pcs) Table 53. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Application (2022-2027) Table 54. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2022-2027) & (US$ Million) Table 55. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application (2022-2027) Table 56. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 58. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 59. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Table 60. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 61. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Table 66. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Table 72. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 73. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 74. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 75. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 76. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 77. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 78. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 79. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 80. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 84. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Country (2022-2027) Table 112. Gilead Sciences Corporation Information Table 113. Gilead Sciences Introduction and Business Overview Table 114. Gilead Sciences Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Gilead Sciences Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 116. Gilead Sciences Recent Development Table 117. Cipla Corporation Information Table 118. Cipla Introduction and Business Overview Table 119. Cipla Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. Cipla Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 121. Cipla Recent Development Table 122. Emcure Pharmaceuticals Corporation Information Table 123. Emcure Pharmaceuticals Introduction and Business Overview Table 124. Emcure Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 125. Emcure Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 126. Emcure Pharmaceuticals Recent Development Table 127. Mylan Pharmaceuticals Corporation Information Table 128. Mylan Pharmaceuticals Introduction and Business Overview Table 129. Mylan Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 130. Mylan Pharmaceuticals Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 131. Mylan Pharmaceuticals Recent Development Table 132. Sun Pharmaceutical Industries Corporation Information Table 133. Sun Pharmaceutical Industries Introduction and Business Overview Table 134. Sun Pharmaceutical Industries Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 135. Sun Pharmaceutical Industries Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 136. Sun Pharmaceutical Industries Recent Development Table 137. Veritaz Healthcare Corporation Information Table 138. Veritaz Healthcare Introduction and Business Overview Table 139. Veritaz Healthcare Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 140. Veritaz Healthcare Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 141. Veritaz Healthcare Recent Development Table 142. Alkem Laboratories Corporation Information Table 143. Alkem Laboratories Introduction and Business Overview Table 144. Alkem Laboratories Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 145. Alkem Laboratories Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Table 146. Alkem Laboratories Recent Development Table 147. Key Raw Materials Lists Table 148. Raw Materials Key Suppliers Lists Table 149. Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Trends Table 150. Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Drivers Table 151. Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Challenges Table 152. Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Restraints Table 153. Efavirenz/Tenofovir/Emtricitabine Combination Drug Distributors List Table 154. Efavirenz/Tenofovir/Emtricitabine Combination Drug Downstream Customers Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Efavirenz/Tenofovir/Emtricitabine Combination Drug Product Picture Figure 2. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 10 Tables Figure 6. Global 10 Tables Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 30 Tables Figure 8. Global 30 Tables Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type (2016-2021) Figure 12. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type (2022-2027) Figure 14. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 15. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type in 2020 Figure 16. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 17. Europe Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type in 2020 Figure 20. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Efavirenz/Tenofovir/Emtricitabine Combination Drug Revenue in 2020 Figure 26. Efavirenz/Tenofovir/Emtricitabine Combination Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Clinic Figure 30. Global Clinic Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Drug Center Figure 32. Global Drug Center Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application (2016-2021) Figure 38. Global Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Efavirenz/Tenofovir/Emtricitabine Combination Drug Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Efavirenz/Tenofovir/Emtricitabine Combination Drug Manufacturing Cost Structure Figure 44. Efavirenz/Tenofovir/Emtricitabine Combination Drug Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Gilead Sciences Cipla Emcure Pharmaceuticals Mylan Pharmaceuticals Sun Pharmaceutical Industries Veritaz Healthcare Alkem Laboratories